Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eberhard Durr

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Methods and Protocols|April 27, 2023
A Robust Protocol to Isolate Outer Membrane Vesicles from Nontypeable <i>Haemophilus influenzae</i>M Daben J Libardo, Eberhard Durr, Lorraine D Hernandez
Vaccine|May 16, 2022
A novel high throughput assay to quantify Epstein-Barr virus neutralizing antibody activity against B-cell and epithelial cell infections for vaccine and therapeutic developmentsFengsheng Li, Daniel Freed, Gwendolyn Heidecker, et al.
Journal of Virology|January 5, 2023
The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine CandidateLori McGinnes Cullen, Bin Luo, Zhiyun Wen, et al.
Journal of Proteome Research|March 21, 2003
Code developments to improve the efficiency of automated MS/MS spectra interpretationRovshan G Sadygov, Jimmy Eng, Eberhard Durr, et al.
Vaccines|February 26, 2022
Evaluation of HSV-2 gE Binding to IgG-Fc and Application for Vaccine DevelopmentJennifer D Galli, Melanie Horton, Eberhard Durr, et al.
Nature|June 11, 2004
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapyPhil Oh, Yan Li, Jingyi Yu, et al.
Nature Biotechnology|July 20, 2004
Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell cultureEberhard Durr, Jingyi Yu, Karolina M Krasinska, et al.
Vaccine|October 21, 2018
Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stabilityLan Zhang, Eberhard Durr, Jennifer D Galli, et al.
Plos One|October 21, 2016
Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion GlycoproteinJessica A Flynn, Eberhard Durr, Ryan Swoyer, et al.
Journal of the American Society for Mass Spectrometry|November 30, 2023
Dissecting the Heterogeneous Glycan Profiles of Recombinant Coronavirus Spike Proteins with Individual Ion Mass SpectrometryAlyssa Q Stiving, David J Foreman, Zachary L VanAernum, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Methods and Protocols|April 27, 2023
A Robust Protocol to Isolate Outer Membrane Vesicles from Nontypeable <i>Haemophilus influenzae</i>M Daben J Libardo, Eberhard Durr, Lorraine D Hernandez
Vaccine|May 16, 2022
A novel high throughput assay to quantify Epstein-Barr virus neutralizing antibody activity against B-cell and epithelial cell infections for vaccine and therapeutic developmentsFengsheng Li, Daniel Freed, Gwendolyn Heidecker, et al.
Journal of Virology|January 5, 2023
The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine CandidateLori McGinnes Cullen, Bin Luo, Zhiyun Wen, et al.
Journal of Proteome Research|March 21, 2003
Code developments to improve the efficiency of automated MS/MS spectra interpretationRovshan G Sadygov, Jimmy Eng, Eberhard Durr, et al.
Vaccines|February 26, 2022
Evaluation of HSV-2 gE Binding to IgG-Fc and Application for Vaccine DevelopmentJennifer D Galli, Melanie Horton, Eberhard Durr, et al.
Nature|June 11, 2004
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapyPhil Oh, Yan Li, Jingyi Yu, et al.
Nature Biotechnology|July 20, 2004
Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell cultureEberhard Durr, Jingyi Yu, Karolina M Krasinska, et al.
Vaccine|October 21, 2018
Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stabilityLan Zhang, Eberhard Durr, Jennifer D Galli, et al.
Plos One|October 21, 2016
Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion GlycoproteinJessica A Flynn, Eberhard Durr, Ryan Swoyer, et al.
Journal of the American Society for Mass Spectrometry|November 30, 2023
Dissecting the Heterogeneous Glycan Profiles of Recombinant Coronavirus Spike Proteins with Individual Ion Mass SpectrometryAlyssa Q Stiving, David J Foreman, Zachary L VanAernum, et al.
Pageof 2